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Experience in human hepatic transplanta-
tion began in March 1963, at the University of 
Colorado. A child, dying of biliary atresia, sur-
vived only a few hours after receiving the first 
orthotopic liver transplant. By September 1980, 
184 patients had been transplanted in this pro-
gram and 16 had been transplanted twice. The 
final patient, also a child with biliary atresia, is 
now alive and well. The total experience with 
hepatic transplantation now consists of over 300 
patients worldwide. The second largest series 
of patients has been reported from the Cam-
bridge-King's College Hospital, London (CaIne 
and Williams, 19i9). 
The initial successes were few, and it was 
not until 1967 that the first liver transplant that 
would survive for a year was performed. These 
early cases have been thoroughly reviewed in 
an earlier monograph on this subject (Starzl, 
1969). Patient survival gradually improved until 
in 1979 a series of 30 patients with 1 year 
survival of 50 per cent was reported (Starzl, 
1979). Finally, those patients most recently 
transplanted will probably exceed 75 per cent 
1 year survival. 
This period of development at the Univer-
sity of Colorado produced techniques compati-
ble with prolonged patient survival. Both the 
University of Colorado and Cambridge-King's 
College centers have enjoyed the greatest suc-
cess with the orthotopiC hepatic transplant. 
Both the operative indication of irreversible 
hepatic failure and the possible competition for 
vital hepatotrophic factors necessitate the re-
moval of the native liver. Transplantation of the 
liver homograft to the original upper abdominal, 
Or orthotopic, site is thus favored. 
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Auxiliary transplantation or preservation of 
the diseased liver with transplantation of the 
homograft liver into a heterotopic site, usually 
the lower abdomen or iliac fossa, is advanta-
geous when eventual recovery of the native 
liver is anticipated. The relatively brief period 
between diagnosis and death in acute liver 
failure has precluded extensive use of auxiliary 
hepatic transplantation. The longest survivor of 
an auxiliary transplant actually suffered from 
chronic disease. Following the transplant there 
was continued deterioration of his native liver 
with eventual assumption of all hepatic function 
by the auxiliary homograft (Fortner et al., 1979). 
The overwhelming preponderance of orthotopic 
transplants, however, reflects the current con-
sensus of restriction of auxiliary transplantations 
to severe acute hepatic failure with a potential 
for eventual recovery. 
INDICATIONS FOR HEPATIC 
TRANSPLANTATION 
Hepatic transplantation is extraordinary 
therapy for progressive liver disease that is 
unresponsive to conventional therapy. Terminal 
hepatic failure should be anticipated within 1 
year. Accelerated deterioration of progressive 
liver disease is usually the best indication of 
impending hepatic failure. The decision to uti~ 
lize transplantation in hepatic failure should be 
resolved before multi-organ failure intervenes. 
The patient must be able to withstand the rigors 
of a long and arduous operation. For this reason, 
disease should be confined to the hepatobiliary 
617 
618 
Table 50-1. Indications for Orthotopic 
Hepatic Transplantation at University of Colorado, 
March 1963 through September 1980-Adults 
19 to 68 years 
Diagnosis 
Chronic active hepatitis 
Laennec's cirrhosis 
Primary hepatic malignancy 
PrimarY biliarY cirrhosis 
Scleros'ing ch~langitis 
Budd-Chiari syndrome 
Secondary biliary cirrhosis 
Inborn errors of metabolism 
Aipha)-antitrypsin deficiency (2) 
Protoporphyria (1) 
Biliary hypoplasia 
Total 
Number of 
Patients 
36 
16 
15 
9 
I> 
4 
3 
3 
2 
96 
system where immediate improvement would 
result from transplantation. Systemic infection 
and hypotension requiring ionotropic support 
have most often precluded transplantation. He-
patic encephalopathy, even coma, and the he-
patorenal syndrome have not precluded trans-
plantation, as these have resolved promptly 
following surgery. Usually the most difficult 
decision is not which patients are candidates for 
liver transplantation, but, rather, when is the 
proper time. As results have improved, earlier. 
surgery has further decreased the operative 
risk. 
Slightly over half of the patients trans-
planted have been adults. The majority of these 
patients were transplanted for chronic active 
hepatitis, Laennec's cirrhosis, or primary he-
patic malignancy (Table 50-1). More recently, 
primary biliary cirrhosis, sclerosing cholangitis, 
and the Budd-Chiari syndrome have offered 
promising results. 
Chronic Active Hepatitis 
Chronic active hepatitis has been the most 
common operative indication in adults and older 
children. The timing of transplantation is diffi-
cult. The onset of the disease is often very 
difficult to date. Furthermore, determining the 
activity of the disease may be difficult because 
of biopsy sampling error or of the hazards of 
repeated liver biopsy. The clinical course is the 
best indicator. As episodes of encephalopathy 
become more frequent and the stimulus initi-
ating encephalopathy becomes more subtle, 
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transplantation is appropriate. A debilitated pa-
tient with onlv intervals at home and whose 
diet is severely protein restricted succeeds only 
in increasing the hazards of transplantation. 
Laboratory studies are of limited value. 
Hepatobiliary nuclear scans can give an esti-
mate of hepatocyte function and may reveal a 
hepatoma as the etiology of recent deteriora-
tion. Similarly, depressed albumin synthesis 
and a prolonged prothrombin time that is un-
responsive to phytonadione indicate hepatocyte 
loss. Bilirubin, transaminase, and ammonia lev-
els have been too inconsistent in chronic disease 
to be of significant value. 
The presence of hepatitis B surface antigen 
(HB,Ag) may impose some added risk following 
transplantation. HB,Ag positive patients have 
routinely remained positive for the antigen. 
Two HB,Ag positive patients were treated with 
hyperimmune globulin before, during, and fol-
lowing liver transplantation. Both of these pa-
tients again became antigen positive, with one 
dying of progressive hepatic failure in less than 
1 year. Other transplant patients have tolerated 
the chronic antigenemia very well. Thus, 
chronic active hepatitis, both antigen positive 
and antigen negative, remains a favored indi-
cation for hepatic transplantation. 
Laennec's Cirrhosis 
By simple patient volume, alcoholic cirrho-
sis could easily overwhelm any liver transplant 
effort. Despite large numbers, patient selection 
is very difficult. Two features account for the 
difficulty. First, abstinence will eliminate any 
progression of the disease. Second, acute alco-
holic hepatitis will show at least partial recov-
ery. These features necessitate support and 
observation to insure recovery from any acute 
alcoholic component, then demonstration of in-
adequate hepatic reserve in the abstinent state. 
Nutrition is usually nonexistent in these pa-
tients. 
Four alcoholics have survived over a year 
following liver transplantation. Two have 
stopped drinking and are doing very well. One 
man demonstrates marked transaminas~ eleva- . 
hon during binge drinking. His liver biopsy 
reveals cirrhosis developing in his homograft. 
The other alcoholic moderates his alcohol COD-
sumption with street drugs. His liver biopsy 
remains healthy. 
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Cirrhosis Arising from the Biliary 
Tract 
Primary biliary cirrhosis, secondary biliary 
cirrhosis, and sclerosing cholangitis tend to be 
slowly but predictably progressive. Encepha-
lopathy is unusual, but pruritus can be excru-
ciating. Prolonged invalidism and constant pru-
ritus drive these patients to transplantation. In 
primary biliary cirrhosis, the patients tend to 
be older but the surgery easier. In secondary 
biliary cirrhosis and sclerosing cholangitis, the 
patients are younger, but multiple previous 
surgical attacks on the biliary tract make the 
hepatectomy treacherous. 
Budd-Chiari Syndrome 
Four patients have been transplanted for 
the Budd-Chiari syndrome. All are alive and 
well at this time. The rapidly progressive course 
of this disease frequently produces hepatic fail-
ure while nutrition and other svstems are only 
modestly impaired. One of th~se women ha's 
even had a child follOwing her liver transplant. 
Slightly less than half of the orthotopic 
liver transplants performed at the University of 
Colorado have been in pediatric patients of age 
18 or younger. The vast majority of these pa-
tients were young children with biliary atresia 
(Table 50-2). Chroilic active hepatitis was more 
common in older children. Recently, an increas-
ing number of children are being transplanted 
for inborn errors of metabolism. 
Table 50-2. Indications for Orthotopic 
Hepatic Transplantation at University of Colorado, 
March 1963 through September 1980---Children 
.,; 18 years 
Diagnosis 
Biliarv atresia 
Chro~ic active hepatitis 
Inborn errors of metabolism 
Alpha,-antitrypsin deficiency (8) 
Wilson's disease (2) 
Tyrosinemia (1) 
Glycogen storage disease IV (1) 
Primary hepatic malignancy 
Neonatal hepatitis 
Congenital biliary cirrhosis 
SecondarY biliarv cirrhosis 
fntrahep~tic choiestasis 
Total 
;:\lumber of 
Patients 
53 
13 
12 
4 
2 
2 
1 
1 
88 
Biliary Atresia 
Fifty-three children were transplanted for 
biliary atresia. Jaundice appearing early in life 
from biliary atresia, and not treated by portoen-
terostomy, has an early fatal outcome, and these 
children are obvious transplant candidates" 
Those children receiving an early portoenter-
ostomy, but with a suboptimal response, are 
more difficult. Cirrhosis still occurs, but per-
haps at a slower rate, and timing for transplan-
tation is more difficult. Technically, the pre-
existing portoenterostomy makes biliary recon-
struction following transplantation easier and 
safer. Any improvement from portoenterostomy 
delaying cirrhosis also permits further growth, 
which increases the likelihood of suitable donor 
availability. 
Inborn Errors of Metabolism 
Twelve children and three adults were 
transplanted for inborn errors of metabolism, 
the most common disease being alphal-antitryp-
sin deficiency. Less than one quarter of homo-
zygotes deficient for alphal-antitrypsin develop 
progressive cirrhosis. Microscopically, hepato-
cyte injury is not clear. With biopsy docu-
mented progressive cirrhosis, hepatic transplan-
tation is indicated. Serum alphal-antitrypsin 
levels are restored and alpha globulins are not 
accumulated in the liver homograft (Hood et 
al., 1980). 
In two children with Wilson's disease who 
developed cirrhosis-producing hepatic failure 
prior to the introduction of penicillamine, liver 
transplantation produced normal ceruloplasmin 
levels, a massive cupruresis, and gradual reso-
lution of the neurological deficit. Both children 
survived over 5 years and one is still alive 
(Starzl et al. 1978). 
CONTRAINDICATIONS TO 
ORTHOTOPIC HEPATIC 
TRANSPLANTATION 
Age 
Few patients over age 50 have been trans-
planted, and none have been transplanted in 
the past 5 years. The longest survival in a 
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patient older than 50 was 87 days. Age 50 has 
thus been regarded as the upper age limit. 
Between the ages of 45 and 50, candidates are 
a better risk. Patients with primary biliary cir-
rhosis usually fall into this latter category. 
Hepatic Malignancy 
Malignancy that is metastatic to the liver 
is a clear indication of systemic disease and, as 
such, has been a contraindication to transplan-
tation. Malignancy arising in the liver is also a 
systemic disease, though this was not initially 
so apparent. Originally, extensive hepatic ma-
lignancy without obvious extrahepatic metas-
tases was considered an indication for total 
hepatectomy and transplantation. Patients with 
hepatoma, cholangiocarcinoma, bile duct can-
cer, and angiosarcoma have been transplanted. 
Eleven patients lived beyond 3 months and 
nine have died of metastatic disease, usually 
within the livex; homograft. However, consid-
erable palliation has been achieved in bile duct 
carcinoma, with one patient living just over 5 
years. Similarly, the Cambridge-King's College 
series experienced a high recurrence rate 
(CaIne and Williams, 1979). Hepatic transplan-
tation in malignancy is now restricted to tumors 
with unusual pathological features and demon-
strated extremely slow growth characteristics. 
Portal Vein Thrombosis 
Portal vein revascularization is critical to 
graft function. Portal vein thrombosis occurring 
even months following transplantation has re-
sulted in graft necrosis. Consequently, portal 
vein patency must be ascertained before any 
irreversible steps during the recipient hepatec-
tomy. Cavernous transformation of the portal 
vein has prevented adequate portal flow and 
can occasionally be difficult to detect until di-
vision of the portal vein. An attempt to re-
establish portal perfusion by vena caval trans-
position was not successful. 
A previous portacaval shunt may be helpful 
because portal hypertension is not aggravated 
by portal clamping. Mesocaval "H" graft shunts 
have been difficult to take down during trans-
plantation. This type of shunt should be avoided 
in patients who may eventually be considered 
for transplantation. The most convenient shunt 
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is the distal splenorenal shunt. Following trans-
plantation of the liver, a splenectomy is per-
formed effectively taking down the shunt. He-
patic artery thrombosis is not a problem but 
occasionally requires anastomosis of the homo-
graft hepatic artery directly to the aorta. 
Systemic Infection 
Cholangitis and spontaneous bacterial per-
itonitis have frequently been observed in pa-
tients coming to transplantation. These infec-
tions have responded well to liver transplant. 
Other infectious sites, especially abdominal ab-
scesses or fistulae, have been disastrous. 
Acute Hepatitis 
Acute hepatitis with massive hepatic necro-
sis is usually not an indication for orthotopic 
transplantation. Almost complete recovery can 
follow even severe cases, precluding hepatec-
tomy and transplantation until late in the course 
of the disease. Auxiliary transplantation may 
also be used to provide temporary support. 
PREOPERATIVE ASSESSMENT 
AND SUPPORT OF THE LIVER 
RECIPIENT 
Candidates for liver transplantation are 
usually referred by hepatologists, but a signi6. 
cant number are self-referred. Medical 
and biopsy slides are requested and TP\np'Nf"I.l. 
The vast majority of self-referrals are 
at this· stage. Patients who conform to 
indication and contraindication guidelines 
admitted for further evaluation. 
Assessment of liver disease is usually 
pie ted prior to admission. A biopsy may 
repeated if the forwarded specimen is felt to 
inadequate, but this is usually avoided. 
nuclide scans are usually performed to e"-;-~­
malignancy as the etiology of recent deteriora-
tion. Angiography is used only for suspected 
malignancy or portal vein thrombosis. YenJlO(r 
vography is performed for the Budd-ChiaO 
drome. The most difficult decision is 
timing. Laboratory studies are of limited 
The best indicator of the appropriate timt' 
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transplantation remains the previous medical 
records. Decreasing periods out of the hospital, 
more frequent episodes of encephalopathy or 
cholangitis, and debilitating pruritus establish 
the appropriate time for transplantation. 
Extrahepatic disease is investigated and 
treated. Respiratory therapy is initiated, and 
frequently thoracentesis is necessary. Most pa-
tients are panendoscoped. Hepatorenal patients 
undergo hemodialysis. Nutrition is pushed to 
the maximum protein load tolerated. Intensive 
nursing care is necessary to avoid aspiration and 
decubitus in encephalopathic patients. 
Bleeding is common, but must be localized 
and controlled. Several patients have been 
transplanted with their Sengstaken-Blakemore 
tubes in place. Hemorrhoids can be even more 
difficult to control. 
Since there is no artificial liver support, 
the best treatment for the patient accepted for 
transplantation is prompt procurement of a suit-
able donor liver. Though the patient is precar-
iously close to death at this point, transplanta-
tion is the safest option. 
DONOR SELECTION AND 
PRESERVATION 
Donor Selection 
The greatest asset to the liver transplant 
program is an active kidney transplant program 
with an aggressive transplant coordinator. The 
ideal donor is a heart-beating, brain-dead young 
adult or child with good visceral perfusion. 
Good urine output remains the best indicator 
of liver perfusion. Fluids that may have been 
restricted prior to brain death are now pushed. 
Cardiotropic drugs are given as needed. Poten-
tial donors are eliminated if thev are over 50 or 
have a history of malignancy, sy~temic infection, 
or hepatitis. Toxicology screens are performed 
prior to determining brain death, but evidence 
of ingestion of hepatotoxic drugs also needs to 
be evaluated. Acetaminophen ingestions have 
been regarded as unacceptable. 
The recipient has then been selected based 
on the donor's size, ABO group, and nonreac-
tivity on the cytotoxic crossmatch. In desperate 
situations, even ABO incompatibility and posi-
tive cytotoxic crossmatches have been accepted 
without evidence of hyperacute rejection. 
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Donor Hepatectomy 
The abdomen is opened through a large 
cruciate incision; it has generally been unnec-
essary to open the chest. The falciform ligament 
if ligated and divided. Both right and left tri-
angular ligaments are divided, with ligation of 
even small vessels, which may ooze later in the 
recipient. Inspection of the liver at this point 
permits hepatectomy of the recipient to be 
initiated. The right and left kidneys are com-
pletely mobilized to the cava and aorta, but 
these vessels and the ureters are left intact. 
The kidneys are later removed just prior to 
actual removal of the liver. 
The suprahepatic vena cava is circumfer-
entially dissected from the level of the most 
superior hepatic vein to well above the dia-
phragm. The membranous portion of the dia-
phragm is partially opened and the right, left, 
and posterior phrenic veins are ligated and 
divided (Fig. 50-1). A generous suprahepatic 
cuff is a luxury greatly appreciated during trans-
plantation. Dissection around the vena cava 
inferiorly to the already dissected renal veins 
requires only division of the right adrenal 
vein{s) and of the peritoneum of the lesser sac 
to the left of the cava. 
Dissection of the common bile duct begins 
as distally as possible in the porta hepatis, 
reflecting the duodenum anteriorly to divide it 
at its junction with the duodenum. The divided 
duct is carefully inspected to ensure that the 
cystic duct has already entered to form a single 
lumen. As much surrounding tissue as possible 
is preserved with the duct to enhance its vas-
cularity. The gallbladder is opened at its fundus, 
and bile is irrigated from the biliary tree with 
saline. 
Dissection of the hepatic artery begins 
distally in the porta hepatis, ligating and divid-
ing the gastroduodenal and right gastric arteries 
at their junction with the hepatic artery. A right 
hepatic artery from the superior mesenteric 
may be present in 15 to 20 per cent of donors 
and is dissected prior to the bile duct. Before 
proceeding farther, the gastrohepatic ligament 
is carefully divided, and if an anomalous left 
hepatic artery is found it is preserved and 
dissected to its junction with the left gastric or 
celiac artery. Dissection of the proper hepatic 
artery is then continued to, and including, the 
celiac trunk 
The portal vein is dissected last. The cor-
onary vein is ligated and divided, permitting 
622 
Right 
I abe ,. 
the portal vein to be bluntly dissected to the 
junction of the superior mesenteric and splenic 
veins. The pancreas is usually divided anteriorly 
to facilitate dissection of the portal vein. 
The kidneys are removed and perfused 
first. The superior mesenteric vein is divided 
and perfused with chilled Ringer's lactate. The 
aorta is clamped and the celiac artery removed 
with an aortic cuff. The cava is divided with 
long cuffs, and the graft is removed. 
Preservation 
Transplantation always necessitates graft 
protection by hypothermia. The portal vein is 
divided first, and perfusion with cold lactated 
Ringer's solution is begun. The liver is re-
moved, and the hepatic artery is briefly rinsed 
with the same solution. For immediate reim-
plantation, the portal perfusion is maintained 
as the caval anastomoses are completed. Con-
tinued perfusion maintains hypothermia and 
flushes trapped air. 
When a longer ischemic period is neces-
sary, as in transfer from another city, an intra-
cellular electrolyte solution is used. At the 
University of Colorado, 4°C Collins solution has 
been effective (Benichou et al., 1977). A slightly 
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Figure 50-I. The suprahepatic 
inferior vena cava (1. V. C.) is generously 
dissected during the donor hepatec-
tomy. The left hepatic vein (L.H.V.) 
may be exposed but preserved while the 
phrenic veins are divided to provide 
additional length. (From StaTZ!, T E., 
and Putnam, C. W.: Experience in He-
patic Transplantation. Philadelphia, W. 
B. Saunders Co., 1969.) 
different plasma solution has been utilized at 
Cambridge-King's College hospital (Wall et al., 
1977.) After perfusion and immersion in these 
solutions, the liver is packed in ice for transit. 
Just prior to implantation, perfusion of the graft 
is begun with iced lactated Ringer's solution to 
flush the storage solution and to maintain hy-
pothermia. 
TECHNIQUE OF ORTHOTOPIC 
TRANSPLANTATION 
Recipient Hepatectomy 
The initiation of the recipient's operatiOD 
occurs when the donor liver is first examined 
and felt to be normal. Since the recipient 
atectomy is frequently lengthy, it must be 
gun concurrently with the donor hel[)atec1toDIJ 
to avoid unnecessarily prolonged ischemia 
the graft. When the recipient and donor 
tectomies are in different cities, the rpc·iOleOI 
surgery is begun when the donor surgeon 
to confirm that the liver looks acceptable. 
The recipient is carefully positioned in 
slightly right anterolateral position. A 
subcostal incision is made (Fig. 50-2, 
B-B). For added exposure, a vertical 
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Figure 50-2. Subcostal incision with various exten-
sions provides adequate exposure in hepatic transplantation. 
(From Starzl, T. E., etal.: Surg. Gynecol. Obstet. 142:487, 
1976. By permission of Surgery, Gynecology and Obstet-
rics. ) 
incision with excision of the xyphoid is added 
(Fig. R~OI C-C). In older adults with rigid 
costal margins, a thoracic extension is made 
from the subcostal margin into the right sixth 
or seventh interspace (Fig. 50-2, 0-0). When 
a midline abdominal incision is used, it is alwavs 
extended across the costal margin into the sixth 
interspace. 
The porta hepatis is dissected first, care-
fully ligating lymphatics and even the tiniest 
vessels. The portal vein is circumferentially 
dissected and very carefully examined for pat-
ency, but is not divided. Any cholangiodigestive 
anastomoses are taken down. When present, 
the cystic duct is ligated and divided, with 
dissection of the common hepatic duct to its 
bifurcation. The hepatic artery is then dissected 
to the junction with the gastroduodenal artery. 
At this point, only the intact duct and vessels 
remain at the porta hepatis. Extensive bleeding 
from divided adhesions on the inferior hepatic 
surface may require division of the vessels at 
the porta hepatis at any ti~eI but preferably 
they are retained until dissection is complete. 
Anomalous hepatic arteries arising from the 
superior mesenteric or left gastric arteries are 
not preserved, as they will not be used in 
reconstruction. 
The remainder of the liver is mobilized in 
similar fashion to the donor hepatectomy, al-
though portal hypertension usually makes the 
procedure more tedious. There is no need to 
dissect long caval cuffs beyond the liver, but, 
rather, when the cava is clamped the caval cuffs 
are developed from the intrahepatic cava, fre-
quently dividing the hepatic veins as they enter 
the cava. The portal structures are clamped and 
divided just prior to clamping the cava. 
After removal of the liver, a thorough 
search is made for bleeding. Caval cuffs are 
inspected and holes from small hepatic veins 
are repaired. 
Orthotopic Transplant Operation 
The homograft liver is inserted exactly as 
the diseased liver was removed. Continuous 
perfusion is maintained, or is reinstituted, 
through the portal vein as the anastomoses are 
completed. This perfusion will maintain hypo-
thermia and Bush air trapped in the hepatic 
veins. 
The suprahepatic cava is anastomosed first. 
The posterior wall is anastomosed from within 
the lumen with great caution, since later rein-
forcement of this suture line is very difficult 
because of the bulk of the graft. The infrahepatic 
cava is anastomosed next, although the cava is 
not declamped. The liver is massaged and per-
fusion is increased to remove all air prior to 
trying the infrahepatic suture. 
With the liver in the orthotopic position, 
perfusion is terminated and the portal vein is 
trimmed to avoid redundancy. The portal vein 
is anastomosed end to end. If interruption of 
caval return has been a problem, the cava and 
portal vein can be declamped. If the recipient 
is stable, the hepatic artery will be anastomosed 
next. The hepatic artery can be anastomosed at 
any point, including directly on the aorta. but 
the most common site is to the proper hepatic 
artery at the bifurcation with the gastroduode-
nal. The gastroduodenal artery is divided, and 
this bifurcation is anastomosed end to end to 
the graft hepatic artery. FollOwing declamping, 
hemostasis is secured. Hemostasis is primarily 
a function of the homograft liver, and consid-
erable delay may occur at this point if the graft 
has sustained any injury. The graft should as-
sume a good color and turgor within 5 minutes, 
and evidence of clotting should be apparent in 
the wound within 15 minutes. 
Hypersplenism is usually present, necessitat-
624 
ing splenectomy to alleviate the hypersplenism 
and to facilitate abdominal closure. Splenec-
tomy is perlormed earlier, during the hepatec-
tomy, only when splenomegaly would cramp 
insertion of the graft; otherwise, the spleen is 
removed when clotting has improved and the 
portal hypertension has been alleviated. 
Finally, biliary drainage is re-established. 
The homograft common bile duct is cut back 
until bleeding from the divided stump is en-
countered. The recipient common hepatic duct, 
divided at its bifurcation, is probed to the 
duodenum. In the absence of primary bile duct 
disease, a choledochocholedochostomy is pre-
ferred (Fig. 50-3 D). A T-tube is placed in the 
recipient common hepatic duct, usually with 
the long arm exiting from the recipient cystic 
duct. The proximal limb extends across the 
anastomosis into the graft common bile duct. 
The anastomosis is end to end with interrupted 
5-0 polyglycolic acid sutures. The distal limb 
of the T-tube is quite short. After an acceptable 
anastomosis, the graft cystic duct is ligated and 
T-tube in recipient 
common duct 
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divided. The gallbladder is removed, and drains 
are placed near the anastomosis. A late follow-
up retrograde cholangiogram demonstrates a 
considerable distance between the two cvstic 
duct stumps (Fig. 50-4). . 
When the recipient common bile duct is 
diseased, a roux-en-Y cholecystojejunostomy is 
preferred. A previously constructed jejunal 
limb is used if available, otherwise a long jejunal 
limb is constructed. The end of the jejunal limb 
is anastomosed inferiorly to the fundus of the 
gallbladder in two laye~s (Fig. 50-3 B). The 
open end of the common bile duct is ligated 
with a nonabsorbable suture. No drains are 
used. 
If the patency of the cystic duct is in 
question and the recipient's common bile duct 
is diseased, a choledochojejunostomy is neces-
sary (Fig. 50-3 C). The anastomosis is over a 
stent with an absorbable inner layer and a 
nonabsorbable outer layer. The stent exits from 
the side of the jejunal limb. The gallbladder is 
removed and drains are placed near the anas-
Figure 50-3. Four methods 
hiliary drainage employed in ortho-
topic hepatic transplantation: A. 
Cholecvstoduodenostomv is 110 
longer performed becaus~ of a high 
complication rate. B, Cholecystoje-
junostomy is necessary when the 
liver recipient's own bile duct is 
eased and cannot be used. C. Clio-
ledochojejunostomy usually rMults 
from surgical revision of a dIOIL-cyI" 
tojejunostomy obstructed at the 
tic duct. D, 
chostomy is preferred 
possible. The T-tube 
from either the donor or 
cystic duct stump. (From 
E., et aI.: Surg. dyne~DEFfK 
142:487, 1976. By permission ci 
gery, Gynecology and Obsll"lrics.) 
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Figure 50-4. Retrograde cholangio-
gram demonstrates unique feature ofliver 
transplants-two cystic duct stumps. Vas· 
cularity of the bile duct usually permits 
considerable redundancy. 
.-
tomosis. The wound is closed in the routine 
fashion. Cholecystoduodenostomy (Fig. 50-3 
A), originally the preferred method of drainage, 
is no longer perfonned because of a high com-
plication rate. 
POSTOPERATIVE MANAGEMENT 
Hemorrhage 
Occasionally a damaged homograft thwarts 
all attempts to achieve hemostasis. Clotting can 
be prolonged by dilution of platelets and clot-
ting factors from excessive bleeding, by con-
sumption within the graft, by intravascular con-
sumption, or simply by failure of the liver to 
replenish clotting factors. Occasionally com-
plete hemostasis is impossible, and sometimes 
it is necessary to close a bleeding wound. Blood 
and fresh frozen plasma are replaced as neces-
sary, and the patient is returned to the intensive 
care unit to await liver recovery. After bleeding 
ceases, it is best to plan on returning to the 
operating room for evacuation of clots. Ifhepatic 
injury occurs in the postoperative period, either 
from rejection or thrombosis, the bleeding dia-
thesis may recur. Late bleeding warrants fur-
ther investigation of the graft. 
Immunosuppression 
Immunosuppression is begun in the oper-
ating room with the administration of 1 gram of 
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methylprednisolone during the vascular anas-
tomoses. Methylprednisolone is continued in 
the postoperative period, initially at 50 mg. 
every 6 hours and then reduced by 20 mg. daily 
until a maintenance schedule of 30 mg. daily is 
reached. Later, oral prednisone is begun at an 
equivalent dosage. Children are begun at 7 mg. 
per kg. per day and follow a similar reduction 
schedule. At 1 year an adult takes about 30 mg. 
of prednisone daily. 
Azathioprine is begun immediately follow-
ing transplantation with the administration of 2 
to 3 mg. per kg. per day. This amount is then 
varied, depending upon the peripheral white 
blood count. Occasionally, with biopsy proven 
intrahepatic cholestasis, azathioprine is discon-
tinued in favor of cyclophosphamide in an 
equivalent dosage. 
Most recently, cyclosporin A has demon-
strated impressive immunosuppressive proper-
ties. It is currently initiated at a dosage of 17.5 
mg. per kg. per day immediately following 
transplantation. It is maintained at this level 
unless nephrotoxicity or hepatotoxicity neces-
sitates a reduction (Starzl et aI., 1981). Dosages 
of half the initial amount have preserved graft 
function while permitting resolution of neph-
rotoxicity. Generally the liver recipients have 
been well maintained on 10 to 12 mg. per kg. 
per day of cyclosporin A. 
With cyclosporin A, neither azathioprine 
nor cyclophosphamide is given. Methylpredni-
solone, however, is given in the same initial 
dose of 200 mg. per day but is then reduced by 
40 mg. per day until a maintenance schedule of 
20 mg. per day is reached. Rejection episodes 
are treated with increased steroid administra-
626 
tion, but cyclosporin A is not increased. Be-
cause of the possibility of cyclosporin A hepa-
totoxicity, in the face of possible rejection 
cyclosporin A is frequently reduced while ste-
roids are temporarily increased. 
Rejection remains an elusive diagnosis. In 
earlier liver transplantations this diagnosis was 
probably made too frequently. Much of the 
improvement achieved after 1976 arose from a 
vigorous diagnostic approach to jaundice. Cho-
langiography, both retrograde and percuta-
neous, became routine. Even the slightest hes-
itation in COl'I.trast How was regarded as partial 
obstruction and biliary revision was undertaken. 
A single liver biopsy has had only limited 
usefulness in the diagnosis of rejection. The 
biopsy is frequently difficult to correlate with 
the clinical course. Serial biopsies have, how-
ever, been of considerable value. Biopsies be-
fore and after changes in steroids or other 
medications have given added confidence in 
biopsy interpretation. Errors in the diagnosis of 
rejection are now much less frequent, but 
chronic irreversible rejection may persist de-
spite intense immunosuppression. The intro-
duction of cyclosporin A as a powerful immu-
nosuppressant with its markedly improved graft 
survival confirms the central role of rejection in 
the earlier immunosuppression schedules. Re-
jection during cyclosporin A administration has 
been responsive to increased steroids, although 
the pathology may be slightly different (Starz} 
et aI., 1981). 
Biliary Obstruction 
Liver homograft function is monitored 
daily for at least a month. Alkaline phosphatase 
is usually the first biochemical test to reHect a 
deterioration in liver function, although biliru-
bin, transaminases, prothrombin time, albu-
min, and globulins are watched daily. Any 
change warrants a tube cholangiogram if a stent 
is still in the biliary tree. If no stent is available, 
an hepatobiliary liver scan is obtained. 
If partial obstruction is suggested by the 
liver scan, or if liver dysfunction persists, a 
cholangiogram is obtained. Now the majority of 
patients have choledochocholedochostomies, 
which are best studied by retrograde cholan-
giography. Stricturing of the bile duct can be 
quite severe without producing proximal dila-
tation. A stricture, even without proximal dila-
tation, warrants operative repair. Normally the 
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intrahepatic ducts appear somewhat smaller 
than are usually seen. The common duct also 
frequently appears angulated at the former exit 
site of the T -tube, and a sinus tract may persist 
for several months, although these findings do 
not indicate obstruction. In one patient a bile 
duct stricture with a spontaneous proximal cho-
ledochoduodenal fistula was actually a recur-
rence of a bile duct carcinoma. 
Retrograde cholangiography is not feasible 
in those liver recipients with cholangiodigestive 
anastomoses. Furthermore, transhepatic cho-
langiography is made more difficult by the 
frequently decreased size of the intrahepatic 
ducts. Ultrasonography of dilated ducts is too 
late a finding and usually is not helpful. The 
cholangiography must be carefully reviewed, 
since the only suggestion of partial obstruction 
may be a delay in emptying or some sludge 
seen only on early films. The most frequent site 
of obstruction has been at the cystic duct; the 
cholecystojejunal anastomoses are rarely, if 
ever, at fault. 
Most of the patients with choledochojeju-
nostomies originally had cholecystojejunosto-
mies that had become obstructed at the cystic 
duct. Approximately 30 per cent of patients 
with cholecystojejunostomies became ob-
structed at the cystic duct. If jaundice persists 
or recurs after conversion to a choledochojeju-
nostomy, transhepatic cholangiography is indi-
cated. Cholangiojejunostomies have generally 
maintained good patency and the majority will . 
demonstrate a normal choledochojejunostomy. 
RESULTS OF LIVER 
TRANSPLANTATION 
1963 to 1976 
Between March 1963 and July 1976, 111 
liver transplants were performed at the Univer-
sity of Colorado. Of these III patients, 31 
patients (28 per cent) survived over 1 year. 
Currently 13 of these patients are still 
with the longest survivor having been 
planted in 1970. 
A review of the first 93 patients indicated 
that mechanical problems, especially biliary ~ 
struction, were the primary causes of death ill 
those patients dying within the first year 
ing operation (Starzl et aI., 1976). Rejection 
an unusual finding in those coming to 
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year, however, rejection was the most common 
factor. In the summer of 1976, a number of 
changes were initiated as a result of this study. 
1976 to 1980 
In July 1976 patient selection eliminated 
patients over age 50, and those with hepatic 
malignancy, from consideration for transplan-
tation. Technical changes in the development 
of vena cava cuffs and microsurgical techniques 
were initiated. The main changes, however, 
were in postoperative management, where an 
aggressive diagnostic approach was adopted. 
Cholangiography, serial liver biopsies, and sur-
gical biliary revision became more common. 
Two years into this period a 50 per cent 1 
year survival was happily reported (Starzl et aI., 
1979). During the latter 2 years of the period a 
decline in survival was _seen, probably related 
to a variety of technical problems and also to 
the employment of thoracic duct drainage for 
lymphocyte depletion (Starzl et a1., 1980). 
In February 1980, this series was com-
pleted, with the last patient treated by conven'-
tional immunosuppression. The survival at 1 
year for adults for the entire period 1963 to 
1980 was 28 per cent (Table 50-3). Children 
enjoyed a slightly improved survival at 1 year 
of 38 per cent (Table 50-4). One hundred 
seventy patients had been transplanted, half 
being children and half adults. . 
Fortunately, the prognosis for those 
achieving the first year milestone improves 
Table 50-3. Results of Orthotopic Hepatic Trans-
plantation at University of Colorado, March 1963 
through February 1980 (Follow-up to February 
1981}-Adults 19 to 68 years 
Number 
Number Living 
of Over 1 
Diagnosis Patients Year 
Chronic active hepatitis 34 11 
Laennec's cirrhosis 16 4 
Primary hepatic malig- 14 3 
nancy 
Primary biliary cirrhosis 8 2 
Sclerosing cholangitis 6 1 
Budd-Chiari syndrome 1 1 
Secondary biliary cirrhosis 1 1 
Inborn errors of metabo- 3 0 
lism 
Biliary hypoplasia 2 1 
Total 85 24 (28%) 
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Table 50-4. Results of Orthotopic Hepatic Trans-
plantation at University of Colorado, .\1arch 1963 
through February 1980 (Follow-up to 
February 1981)-Children ~ 18 years 
Number 
of Number Living 
Diagnosis Patients Over 1 Year 
Biliary atresia 52 15 
Chronic active hepatitis 12 4 
Inborn errors of metabo- 12 8 
lism 
Primary hepatic malig- 4 2 
nancy 
Neonatal hepatitis 2 1 
Congenital biliary cirrho- 2 0 
sis 
Secondary biliary 
cirrhosis 1 2 
Total 85 32 (38%) 
markedly. From the entire series, the majority 
of those alive at 1 year are still alive at this 
time. Those patients dying subsequent to 
achieving 1 year survival were almost invariably 
in trouble and on more immunosuppression at 
1 year. Those patients enjoying normal hepatic 
function at 1 year have usually continued to do 
so and have achieved good rehabilitation (Starzl 
et aI., 1979). Most adults have not returned to 
work, although many have, and the children 
are attending school regularly. 
1980 
Between March 1980 and September 1980, 
14 patients have received liver transplants with 
Table 50-5. Results of OrthotopiC Hepatic Trans-
plantation at Universitv of Colorado March 1980 
through September 1980 Ecollow-u~ to February 
1981) 
Number 
of 
Diagnosis Patients 
Chronic active hepatitis 3 
Budd-Chiari syndrome 3 
Secondary biliary cirrho- 2 
sis 
Sclerosing cholangitis 2 
Primary hepatic malig- 1 
nancy 
Primary biliary cirrhosis 1 
B iliarv . atres ia . 1 
Intrahepatic cholestasis 1 
Total 14 
Number Living 
at5toll 
Months 
3 
3 
1 
1 
1 
o 
11 (79%) 
f 
J 
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cyclosporin A immunosuppression. Eleven of 
these patients are alive at 5 to 11 months 
following their liver transplant (Table 50-5). 
Two of the deaths were operative. All of the 11 
surviving patients from this series currently 
have good hepatic function. These are clearly 
the best results achieved to date. This striking 
improvement in survival, if maintained at a year 
as it apparently will be. would strongly support 
the clinical feasibility of liver transplantation. 
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